Neuropeptide Y Y2 Antagonist Treated Ovariectomized Mice Exhibit Greater Bone Mineral Density

Osteoporosis, a disease characterized by progressive bone loss and increased risk of fracture, often results from menopausal loss of estrogen in women. Neuropeptide Y has been shown to negatively regulate bone formation, with amygdala specific deletion of the Y2 receptor resulting in increased bone...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuropeptides
Auteurs principaux: Seldeen, KL, Halley, PG, Volmar, CH, Rodríguez, MA, Hernandez, M, Pang, M, Carlsson, SK, Suva, LJ, Wahlestedt, C, Troen, BR, Brothers, SP
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805636/
https://ncbi.nlm.nih.gov/pubmed/29129406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.npep.2017.11.005
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires